SRTA Strata Critical Medical, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Strata Critical Medical, Inc. (SRTA) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 3, 2026, a 10-Q quarterly report filed on November 10, 2025, an 8-K current report filed on March 3, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Strata Critical Medical, Inc. (SRTA) (SEC CIK 1779128), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Q4 2025 earnings results disclosed via press release (Exhibit 99.1)
- • Full financial details available in Exhibit 99.1 — no figures disclosed in the 8-K body
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Strata Critical Medical, Inc. (SRTA) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | — | $225.2M | $248.7M | $197.1M |
| Gross Profit | — | — | $29.6M | $41.1M |
| Operating Income | -$53.5M | -$68.1M | -$33.9M | -$22.4M |
| Net Income | -$27.3M | -$56.1M | -$27.3M | $41.3M |
| Gross Margin | — | — | 11.9% | 20.9% |
| Op. Margin | — | -30.3% | -13.6% | -11.3% |
| Net Margin | — | -24.9% | -11.0% | 21.0% |
| Balance Sheet | ||||
| Total Assets | — | $294.9M | $256.7M | $325.5M |
| Equity | $274.5M | $234.3M | $221.9M | $279.1M |
| ROE | -9.9% | -23.9% | -12.3% | 14.8% |
Source: XBRL financial data from Strata Critical Medical, Inc. (SRTA) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
10-K | Mar 3, 2026 | Dec 31, 2025 | — | |
8-K | Mar 3, 2026 | — | Analysis | — |
8-K | Feb 5, 2026 | — | — | |
8-K | Dec 3, 2025 | — | — | |
8-K | Dec 2, 2025 | — | — | |
10-Q | Nov 10, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 5, 2025 | Jun 30, 2025 | — | |
10-Q | May 12, 2025 | Mar 31, 2025 | — | |
10-K | Mar 13, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 8, 2024 | Jun 30, 2024 | — | |
10-Q | May 7, 2024 | Mar 31, 2024 | — | |
10-K | Mar 12, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 8, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 9, 2023 | Jun 30, 2023 | — | |
10-Q | May 11, 2023 | Mar 31, 2023 | — | |
10-K | Mar 16, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 10, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 9, 2022 | Jun 30, 2022 | — | |
10-Q | May 10, 2022 | Mar 31, 2022 | — | |
10-K | Dec 20, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 16, 2021 | Jun 30, 2021 | — | |
10-Q | May 24, 2021 | Mar 31, 2021 | — | |
10-K | Mar 10, 2021 | Dec 31, 2020 | — | |
10-Q | Nov 10, 2020 | Sep 30, 2020 | — |
Frequently Asked Questions
What are the latest SRTA SEC filings in 2026?
Strata Critical Medical, Inc. (SRTA) has filed a 10-K annual report on March 3, 2026, a 10-Q quarterly report on November 10, 2025, an 8-K current report on March 3, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did SRTA file its most recent 10-K annual report?
Strata Critical Medical, Inc. (SRTA) filed its most recent 10-K annual report on March 3, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view SRTA 10-Q quarterly reports?
Strata Critical Medical, Inc. (SRTA)'s most recent 10-Q quarterly report was filed on November 10, 2025. SignalX displays every SRTA 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has SRTA filed recently?
Strata Critical Medical, Inc. (SRTA)'s most recent 8-K was filed on March 3, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find SRTA insider trading activity (Form 4)?
SignalX aggregates every SRTA Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does SRTA file with the SEC?
Strata Critical Medical, Inc. (SRTA) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new SRTA filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Strata Critical Medical, Inc. (SRTA).
What is SRTA's SEC CIK number?
Strata Critical Medical, Inc. (SRTA)'s SEC CIK (Central Index Key) number is 1779128. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1779128 to look up all SRTA filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find SRTA return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Strata Critical Medical, Inc. (SRTA) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Strata Critical Medical, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 29+ filings.